Kimo-Innovation Announces Expiration of Compensation Committee Term
AI Summary (NQ-processed)
Kimo-Innovation (4195) announces the expiration of its Compensation Committee term. Former members萧介夫, 萧育仁, and 程仁宏 have stepped down. New appointments are pending.
AI Analysis
Frequently Asked Questions
Q: What is the Compensation Committee at Kimo-Innovation?
A: An independent body that reviews and recommends executive compensation, enhancing corporate governance transparency.
Q: What was the term of the outgoing committee members?
A: From 112/07/18 to 115/06/06, aligned with the board of directors' term.
Q: When will the new committee members be appointed?
A: Not yet determined, but expected to be announced after the board renewal.
Q: How does this change affect shareholders?
A: A temporary governance gap may arise, making timely reappointment crucial for investor confidence.
Q: What industry is Kimo-Innovation in?
A: Biotech and pharmaceuticals, focusing on innovative drug development.